» Articles » PMID: 34675763

The Clinical Use of Vernier Acuity: Resolution of the Visual Cortex Is More Than Meets the Eye

Overview
Journal Front Neurosci
Date 2021 Oct 22
PMID 34675763
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Vernier acuity measures the ability to detect a misalignment or positional offset between visual stimuli, for example between two vertical lines when reading a vernier scale. It is considered a form of visual hyperacuity due to its detectable thresholds being considerably smaller than the diameter of a foveal cone receptor, which limits the spatial resolution of classical visual acuity. Vernier acuity relies heavily on cortical processing and is minimally affected by optical media factors, making it a useful indicator of cortical visual function. Vernier acuity can be measured, usually in seconds of arc, by freely available automated online tools as well as via analysis of steady state visual-evoked potentials, which allows measurement in non- or pre-verbal subjects such as infants. Although not routinely measured in clinical practice, vernier acuity is known to be reduced in amblyopia, glaucoma and retinitis pigmentosa, and has been explored as a measure of retinal or neural visual function in the presence of optical media opacities. Current clinical utility includes a home-based vernier acuity tool, preferential hyperacuity perimetry, which is used for screening for choroidal neovascularisation in age-related macular degeneration. This review will discuss the measurement of vernier acuity, provide a current understanding of its neuro-ophthalmic mechanisms, and finally explore its utility through a clinical lens, along with our recommendations for best practice.

Citing Articles

Assessment of Emergency Department Intraocular Pressure and Visual Acuity Assessment as a Screening Exam.

Bojikian K, Leveque T, McEvoy A, Hopkin B, Popovici N, Hopkin H Clin Ophthalmol. 2025; 19:683-690.

PMID: 40026816 PMC: 11871949. DOI: 10.2147/OPTH.S511327.


Visual Neurophysiological Biomarkers for Patient Stratification and Treatment Development Across Neuropsychiatric Disorders.

Martinez A, Hillyard S, Javitt D Adv Neurobiol. 2024; 40:757-799.

PMID: 39562463 DOI: 10.1007/978-3-031-69491-2_25.


Minimum visual acuity: a new cone specific clinical test.

Rabin J, Goodroe K, Hood A, Duka C, Dunmon K, Bouaphavong D Eye (Lond). 2024; 39(1):195-197.

PMID: 39333642 PMC: 11733008. DOI: 10.1038/s41433-024-03377-7.


A history of visual acuity testing and optotypes.

de Jong P Eye (Lond). 2022; 38(1):13-24.

PMID: 35922542 PMC: 10764321. DOI: 10.1038/s41433-022-02180-6.


Scotopic Contour Deformation Detection Reveals Early Rod Dysfunction in Age-Related Macular Degeneration With and Without Reticular Pseudodrusen.

Jeffrey B, Flynn O, Huryn L, Pfau M, Cukras C Invest Ophthalmol Vis Sci. 2022; 63(6):23.

PMID: 35749129 PMC: 9234356. DOI: 10.1167/iovs.63.6.23.

References
1.
Westheimer G . Optical superresolution and visual hyperacuity. Prog Retin Eye Res. 2012; 31(5):467-80. DOI: 10.1016/j.preteyeres.2012.05.001. View

2.
Freundlieb P, Herbik A, Kramer F, Bach M, Hoffmann M . Determination of scotopic and photopic conventional visual acuity and hyperacuity. Graefes Arch Clin Exp Ophthalmol. 2019; 258(1):129-135. DOI: 10.1007/s00417-019-04505-w. View

3.
Fine A, Elman M, Ebert J, Prestia P, Starr J, Fine S . Earliest symptoms caused by neovascular membranes in the macula. Arch Ophthalmol. 1986; 104(4):513-4. DOI: 10.1001/archopht.1986.01050160069013. View

4.
Everatt J, Bradshaw M, Hibbard P . Visual processing and dyslexia. Perception. 2000; 28(2):243-54. DOI: 10.1068/p2743. View

5.
McKendrick A, Badcock D, Gurgone M . Vernier acuity is normal in migraine, whereas global form and global motion perception are not. Invest Ophthalmol Vis Sci. 2006; 47(7):3213-9. DOI: 10.1167/iovs.05-1549. View